Ignite Creation Date:
2024-05-06 @ 2:37 PM
Last Modification Date:
2024-10-26 @ 1:34 PM
Study NCT ID:
NCT04375046
Status:
UNKNOWN
Last Update Posted:
2021-06-09
First Post:
2020-05-01
Brief Title:
Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications Better Than Recombinant Human ACE2
Sponsor:
Kafrelsheikh University
Organization:
Kafrelsheikh University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-10
Completion Date Type:
ESTIMATED
First Submit Date:
2020-05-01
First Submit QC Date:
May 1 2020
Study First Post Date:
2020-05-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-06-05
Last Update Post Date:
2021-06-09
Last Update Post Date Type:
ACTUAL